INTRoDuCTIoN
A major population of Neuropeptide Y (NPY)-producing neurons is located in the arcuate nucleus (ARC) of the hypothalamus. Central administration of NPY increases feeding behavior in rodents (184, 227, 228) and NPY has been linked to the control of carbohydrate intake (56, 181) . However, we recently observed that when NPY is administered in the lateral ventricle of rats on a free-choice high-fat high-sugar (fcHFHS) diet, it was not sugar, but rather saturated fat and chow consumption that increased (158) . The link between NPY and carbohydrate intake has been previously studied using administration of NPY into specific hypothalamic regions (53, 56) . In contrast, we administered NPY into the lateral ventricle, providing contact with not only the hypothalamus, but also cortico-limbic areas involved in reward and motivation, such as the nucleus accumbens (Acb) where NPY receptors are localized (51, 229, 230) . It remains to be explored, however, whether direct action of NPY in the Acb regulates fat consumption.
Reduced neuronal activity in the Acb occurs during feeding and intra-Acb administration of orexigenic compounds, such as melanin concentrating hormone and muscimol, inhibit Acb neuronal activity (36, (231) (232) (233) . However, it is not known whether NPY also affects neuronal activity in the Acb. Given that direct NPY administration into other brain areas including the amygdala and ARC reduces neuronal activity (234,235), we hypothesized that NPY reduces Acb neuronal activity and that this is associated with increased fat intake.
Opioids have an established role in reward behavior, and opioid-expressing neurons are located within the Acb. Of the opioid-expressing neurons, enkephalin neurons are of specific interest as they express dopamine D2 receptors (D2R) and have been linked to high-fat feeding; i.e. Acb enkephalin gene expression is affected by consumption of the highly palatable Ensure drink (38), which contains fat and sugar, and striatal D2R availability is correlated with high-fat intake (39). Moreover, enkephalin binds to mu-opioid receptors and local Acb administration of the mu-opioid receptor agonist DAMGO specifically increases intake of high-fat foods (40). In turn, the DAMGO-induced increased intake of high-fat foods is NPY Y1 receptor (Y1R) dependent (236) . Therefore the effect of NPY on fat intake may involve changes in Acb enkephalin levels. Given these findings, we hypothesized that Y1Rs are localized on enkephalin neurons and that intra-Acb NP injection alters striatal enkephalin levels.
Finally, previous studies have revealed anatomic connections between the ARC and Acb (237, 238) as well as the presence of NPY receptors in the Acb (51, 229, 230) . While a recent study found a-MSH projections from the ARC to Acb (239), it has not been determined whether NPY neurons in the ARC project to the Acb.
To examine the action of NPY in the Acb we first assessed food intake and preproenkephalin (ppENK) mRNA responses to intra-Acb NPY injections in rats on the fcHFHS diet. Second, we measured NPY's effects on neuronal activity using in vivo electrophysiology. Third, using fluorescent imaging and retrograde tracing we determined whether Y1Rs are localized on enkephalin and dynorphin neurons and whether NPY neurons in the ARC project to the Acb. We found that intra-Acb NPY stimulates fat intake via the Y1R and is associated with reduced expression of ppENK mRNA and neuronal activity. Moreover, ENK neurons express Y1Rs and NPY neurons in the ARC project to the Acb. These neuroanatomical, pharmacological, and neuronal activity data support a possible role and mechanism for intra-Acb NPY-induced fat intake.
MATERIAL AND METHoDS

Animals
For behavior and radioactive in situ hybridization, male adult Wistar rats (Charles River, Germany) weighing 270-300g were used. For electrophysiological experiments and fluorescent in situ hybridization, C57/BL6 mice (Jackson Labs, Bar Harbor, Maine, USA) weighing 25-30g were used. All animal procedures were performed in accordance with the protocol approved by the Yale Institutional Animal Care and Use Committee and the Committee for Animal Experimentation of the Academic Medical Center of the University of Amsterdam.
Effect of intra-accumbens NPY and Y1R antagonist on food intake
Rats were housed in a temperature (21-23ºC) and light-controlled room (lights on 0700-1900). One week after arrival, rats were implanted with two cannulae aimed bilaterally at the Acb-shell as described in the Supplemental Material. One week after surgery rats (N=15) were placed on a free-choice high-fat high-sugar (fcHFHS) diet and were able to choose from the following components: a dish of saturated fat (Beef tallow (Ossewit/Blanc de Boeuf), Vandemoortele, Belgium), a bottle of 30% sugar water (mixed from commercial grade sugar and tap water), standard chow (special diet service (SDS), England) and tap water. After 1 week of fcHFHS diet exposure, 0.6µg NPY (minimum effective dose in previous experiments (210,240) and own observations) or vehicle (1x phosphate buffered saline (PBS)) was administered at the beginning of the light phase (between 10AM and 11AM) in a balanced design. NPY was obtained from Bachem, Germany (H6375) and dissolved in 1x PBS. Before the start of the experiment, all food components (except water) were removed from the cage. 33-gauge injector cannulae (Plastics One, Bilaney Consultants GmbH, Düsseldorf, Germany), extending 1 mm below the guide cannula, were inserted into the guide cannulae, and animals received bilateral infusions of 0.3μl fluid per site at a rate of 0.15μl/min via a syringe infusion pump. Injections were confirmed by monitoring fluid movement in the tubing via a small air bubble. After the injection completion, the injector was left in place for 1 min to allow for diffusion. Upon completion of all infusions, food was returned to the cages and all individual food components were measured after 2, 5 and 24h, and caloric intake (kcal) for each individual food item and total caloric intake were calculated. Total caloric intake was defined as the sum of each individual food component for which the caloric density was defined as follows: chow: 3.31 kcal/g; fat: 9 kcal/g and sucrose solution: 1.2 kcal/g. The experiment was repeated 3 days later according to a cross-over design.
At the end of the experiment, food was removed in the morning (and not returned) and rats received intra-Acb injection of vehicle or 0.6µg NPY. One hour later rats were anesthetized and transcardially perfused with ice-cold saline followed by 4% paraformaldehyde and post-fixed for 2h. Brains were washed in PBS, cryoprotected in 30% sucrose at 4°C overnight and subsequently frozen on dry ice and stored at -80°C. Cryostat sections were cut at 35µm and mounted on Superfrost Plus slides (Fisher, Gerhard Menzel GmbH, Germany). Some slides were stained for Nissl with Thionine and checked for cannula placement with inclusion criteria described below. Remaining slides were air-dried and stored at -80°C to be used for radioactive in situ hybridization. The procedure for radioactive in situ hybridization was performed as described previously (49) and described in the Supplemental Material.
In a separate experiment, we tested whether the Acb NPY Y1 receptor (Y1R) is involved in the intra-Acb NPY-induced increased fat intake by intra-Acb administration of the Y1R antagonist GR 231118 (synonym of LY1229U91, Sigma Aldrich, Zwijndrecht, the Netherlands) or vehicle (in a volume of 0.2μl) in the Acb 15 min before intra-Acb NPY in rats on the fcHFHS diet (N=15). These experiments were conducted according to the same protocol (for surgery and cannula placement verification) as described above. We only measured intake of chow, fat and sugar at one time point as NPY effects do not show beyond a few hours. The dose of antagonist used (0.3ug) was chosen based on reports published elsewhere (241,242) and on a dose response in a few animals using 0.3, 1 and 3μg antagonist. Since 1 and 3μg in the Acb decreased overall intake, we choose the 0.3μg dose, because it did not significantly affect feeding behavior (data not shown). At the end of the experiment, rats were killed by decapitation and brains were removed, frozen on dry ice and stored at -80°C. Cryostat section were stained for Nissl with Thionine and checked for cannula placement. Data of rats were only included when we verified that they had unilateral or bilateral cannula placements in the Acb-shell between Bregma 1.0 and 2.20 (Paxinos and Watson 4 th ed. 1998) (243,244). Based on these criteria, 5 animals were excluded from analysis from experiment 1, and 1 animal from experiment 2 (with Y1R antagonist). Furthermore, for experiment 2, data from 3 more animals were excluded from analysis due to loss of the cannula or sickness behavior after injection, which turned out to be associated with infection around the cannula.
Fluorescent in situ hybridization
Fluorescent in situ hybridization was performed as described previously (245) and in the Supplemental Material. Probes for double in situ hybridization were prepared using an in vitro transcription kit with digoxigenin-labeled UTP (Roche, Basel, Switzerland) for making the Y1R probe or fluorescein-labeled UTP (Molecular Probes, Eugene, OR, USA) for making the ppENK or prodynorphin probe (information on probes is provided in the Supplemental Material).
In vivo electrophysiology
Four well-habituated C57/BL6 mice (25-30g) were implanted with a cannula (Plastics One) and arrays of microwire electrodes (Tucker-Davis Technologies, Alachua, FL, USA) using aseptic stereotaxic methods described in detail previously (232) and in the Supplemental Material. The arrays consisted of 16 Teflon-coated, 50μm stainless steel wires arranged in an 8×2 configuration, with each electrode spaced by ~250μm. The in vitro impedance of the electrodes was 100-300kΩ. After a recovery period of 5-7d, animals were acclimated to recording procedures (i.e., headsets and cables were attached to the implants) for 1d. Drug infusions were performed as follows. Animals were lightly anesthetized with halothane via a nosecone during the experiment, and recording headstages were plugged in. After initial recording, data acquisition was paused and animals were infused with either aCSF (NaCl 147mM, CaCl 2 1.3mM, MgCl 2 0.9mM, KCl 4.0mM) or NPY (0.6μg). Infusions were made through 33 gauge cannula (Plastics One) that protruded 0.2mm from the tip of the guide cannulae. Injectors were inserted into the guide cannulae and 0.3μl of infusion fluid was delivered per site at a rate of 0.15μl/min via a syringe infusion pump (KDS Scientific, Holliston, MA, USA). Fluid was infused via 0.38-mm-diameter polyethylene tubing that connected the injector to a 5μl Hamilton syringe. Injections were confirmed by monitoring movement of fluid in the tubing via a small air bubble. After injection was complete, the injector was left in place for 2 min to allow for diffusion. Infusions took place between 12:00 and 2:00 PM. Recording data were collected for 1h after infusions.
Neuronal ensemble recordings were made using a Many Neuron Acquisition Program (Tucker-Davis Technologies). Putative single neuron units were identified on-line using an oscilloscope and an audio monitor. The Tucker-Davis Technologies off-line sorter was used to analyze the signals off-line and to remove artifacts due to cable noise and behavioral devices (pump, click stimulus). Principal component analysis (PCA) and waveform shape were used for spike sorting. Single units were identified as having (1) consistent waveform shape, (2) separable clusters in PCA space, (3) average amplitude estimated at least three times larger than background activity, and (4) a consistent refractory period of at least 2 ms in interspike interval histograms. Those units identified on-line as potential single units that did not meet these criteria off-line were not included in this analysis. Datasets were previewed using OpenSorter (Tucker-Davis Technologies) and subsequently analyzed using custom routines for MATLAB. For each well isolated neuron, post-infusion firing rates were normalized to mean pre-infusion firing rates (in the 10 min immediately preceding drug infusion) and binned (60s bins). Activity was then compared between neurons recorded in NPY and aCSF conditions.
At the end of the experiment, mice were perfused transcardially with ice-cold saline followed by 4% paraformaldehyde. After fixation, brains were cryoprotected in 30% sucrose at 4°C overnight. Microtome sections were cut at 40μm along the horizontal axis and mounted on Superfrost Plus slides (Fisher). Electrode and cannulae placement in horizontal sections was verified microscopically using the mouse brain atlas from Paxinos and Watson (1982) .
CTB tracing
One week after arrival, 6 male Wistar rats (Charles River; Sulzfeld, Germany) weighing 270-300g received two cannulae: one aimed at the right Acb shell for infusion of the cholera toxin B (CTB) conjugated to alexa-555 (C-22843, Invitrogen, Bleiswijk, the Netherlands) tracer and one cannula in the left lateral ventricle (LV) for the infusion of colchicine to block neuronal transport (C9754, Sigma-aldrich, Zwijndrecht, the Netherlands). Surgical procedures were the same as for the rat study described above. For the LV a permanent 22-gauge stainless steel guide cannula was used with coordinates 0.8 mm posterior from bregma, 1.4 mm lateral from the midline and 4.5 mm below the surface of the brain. In contrast to CTB, fluorophore-labeled CTB cannot be applied by iontophoresis, so we used pressure injection (237). Rats were injected unilaterally with 100 -150nl 1% CTB into the Acb shell. The injection needle was left in place and fixed with dental cement to the skull to minimize leakage from the tract (237). Twelve days later, rats were deeply anesthetized and 100µg colchicine in 5µL PBS was injected in the LV. 24-36h later, rats were transcardially perfused with saline, followed by a solution of 4% paraformaldehyde in 0.1 M PBS (pH 7.4) at 4°C. Brains were removed and kept in a 30% sucrose solution dissolved in PBS for 2h. Subsequently, the brains were washed briefly with PBS, frozen on dry ice and stored at -80°C until further processing for fluorescent immunohistochemistry. The procedure for the fluorescent immunohistochemistry was performed as described previously (246) and in the Supplemental Material.
Statistical Analysis
For the effects of NPY on food intake and on enkephalin mRNA, t-tests were performed. The data on NPY in combination with the Y1R antagonist were tested with a two-way RM ANOVA (for paired-comparison), and were followed with Sidak's multiple comparisons tests. Data obtained with electrophysiology were analyzed with a repeated-measures ANOVA, followed by Tukey's post hoc tests where appropriate. For all analyses, significance was assigned at the P ≤ 0.05 level. All data are presented as mean ± SEM.
RESuLTS
Effect of NPY and Y1R antagonist in nucleus accumbens on food intake
Local administration of NPY significantly increased fat intake after 2h (Fig 1A) , but not after 5h and 24h (Supplemental Data S1). Intra-Acb NPY did not affect intake of the chow or sugar component after 2h (Fig 1A) or after 5h and 24h (Supplemental Data S1). Subsequently, the effect of pretreatment with the selective Y1R antagonist GR 231118 on NPY-induced fat intake was tested. Again, when infused in the Acb, NPY specifically increased fat intake (Supplemental Data S2). Interestingly, when cannulae were placed bilaterally in the shell of the Acb (which was the case in 5 out of 11 animals), pretreatment with Y1R antagonist completely prevented the NPY-induced increase in fat intake (interaction Pretreatment with Y1-antagonist*NPY (F(1,20)=6.3; P=0.02); a trend for NPY effect: F(1,20)=3.5; p=0.08) and no effect of the Y1 antagonist F(1,20)=1.5; P=0.24) (Fig 1B) .
NPY reduces cell firing in the nucleus accumbens in vivo
To evaluate the effects of NPY on neuronal activity in vivo, neuronal firing data were collected during intra-Acb infusions of aCSF or NPY with microwire recording electrodes implanted in the Acb (Fig 2A,B) . Multi-unit recordings performed under anesthesia revealed a significant reduction in firing rates of Acb neurons treated with 0.6mg NPY (n=29) and a significant interaction between time and treatment P=0.0010, 2-way ANOVA F(39,1482)=1.874) (Fig 2C,D) . Firing in 11/29 (37.9%) units was suppressed 50% below from baseline. Another 9/29 (31.0%) units were suppressed 25% below from baseline. The remaining 9 units were either unchanged (6/29, 20.7%) or increased (3/29, 10.3%) relative to pre-infusion firing rates. This effect lasted 25 min, starting within 5 min after infusion (Fig 2C) .
NPY1R colocalizes with enkephalin and dynorphin positive neurons in nucleus accumbens
Since NPY receptors are present in the Acb (230), we investigated whether Y1R colocalizes with enkephalin and dynorphin neurons by performing double-labeled fluorescent in situ hybridization. Colocalization of Y1R on enkephalin and dynorphin neurons was found throughout the striatum and Acb; about 59% of Y1R colocalized Figure 1 . Effect of intra-Acb NPY in rats on intake of chow, sugar and fat components of the fcHFHS diet. A) NPY in the Acb significantly increased fat intake and not sugar or chow intake; total intake tended to be increased (veh 6.5±0.8 vs. NPY 8.7±1.1; p=0.1) (N=10). B) The increase in fat intake was prevented by pretreatment with Y1R antagonist GR 231118, injected bilaterally into the shell of Acb, whereas the Y1R antagonist did not affect fat intake (or chow and sugar) alone (n=5). Data are presented as mean ± SEM. A significant effect is depicted by *P<0.05 and **P<0.01. Figure 1 . Effect of intra-Acb NPY in rats on intake of chow, sugar and fat components of the fcHFHS diet. A) NPY in the Acb significantly increased fat intake and not sugar or chow intake; total intake tended to be increased (veh 6.5±0.8 vs. NPY 8.7±1.1; p=0.1) (N=10). B) The increase in fat intake was prevented by pretreatment with Y1R antagonist GR 231118, injected bilaterally into the shell of Acb, whereas the Y1R antagonist did not affect fat intake (or chow and sugar) alone (n=5). Data are presented as mean ± SEM. A significant effect is depicted by *P<0.05 and **P<0.01.
with enkephalin neurons (Fig 3a) and about 18% with dynorphin neuron (Supplemental Data S3) as revealed by confocal analysis.
NPY administration in the nucleus accumbens decreases ppENk mRNA expression.
Striatal enkephalin, as opposed to dynorphin, has been described to be affected by changes in energy balance (37). Additionally, we found that Y1R is mainly located on enkephalin neurons. Therefore we investigated the effect of NPY on enkephalin mRNA levels. We quantitatively measured ppENK mRNA levels using radioactive in situ hybridization and found that one hour after intra-Acb NPY administration, ppENK mRNA expression was significantly downregulated in both the ventral striatum (Acb) as well as the dorsal striatum (Fig 3b) (P<0.05) .
Subset of arcuate NPY neurons project to nucleus accumbens
To investigate the origin of NPY neurons projecting to the Acb, the CTB tracer was administered in the Acb and colocalization with NPY antibody was determined. The tracer was mostly concentrated at the border of the medial shell and core, positioned dorsomedially to the ACA (Fig 4a) . Anterograde CTB tracing was found in the medial part of the subcommissural ventral pallidum and lateral hypothalamus confirming previous findings (247-249). In this study our main focus was to investigate afferent projections to the Acb and consequently to determine which of these projections colabel with NPY. Retrograde transport of CTB tracer was examined by serial sectioning and immunostaining in the neocortex, thalamus, hypothalamus, amygdaloid nuclei, ventral pallidum and subiculum.
Consistent with previous studies, CTB staining was found in labelled perikarya in the agranular insular cortex, perirhinal cortex, midline thalamic nuclei and (baso) lateral amygdala (238, 248, 249) . However, in none of these areas did CTB colocalize with NPY staining.
The primary site for synthesis of NPY peptide is the ARC. Consistent with others (237,238), we found CTB staining in the ARC. CTB labeling was present in the ventral medial and ventral lateral part the ARC. In the ventral medial ARC, the majority of Values are means ± SEM of seven to nine rats per group. *P<0.05 NPY vs vehicle.
Chapter 8 CTB cells were dually immunostained with NPY (Fig 4b) , indicating NPY positive cells projecting from the ARC to Acb. This finding was confirmed in 3 successfully injected cases. CTB cells in the lateral portion of the ARC, which did not colocalize with NPY, may be alpha-MSH neurons as melanocortinergic projections from the ARC to Acb have been shown previously (239).
DISCuSSIoN
In the present study, we used a combination of behavioral, neuroanatomical and in vivo electrophysiological measures to investigate the effect of NPY on Acb neuronal activity, neuropeptide expression and behavioral output. We demonstrated that NPY administration in the Acb in rats on the fcHFHS diet increased fat intake specifically, and this effect was attenuated by pretreatment with an Y1R antagonist in the Acb shell. Furthermore, we identified NPY Y1 receptors on ENK neurons in the Acb and found that NPY administration lowered Acb neuronal activity and levels of striatal ppENK mRNA. Finally, we showed that a subset of ARC NPY neurons project to the Acb. Together with our earlier findings that the fcHFHS diet increased NPY mRNA in the ARC and increased sensitivity for NPY (12,158), these findings provide evidence for a role of NPY in the intake of palatable foods, possibly via inhibition of D2-enkephalin neurons. Moreover, the increased levels of NPY mRNA in the ARC observed in rats on the fcHFHS diet may, via projections to the Acb, be related to the increased motivation and active lever pressing as well as the persistent hyperphagia observed in these rats (10, 12) .
Consistent with others, we found that intra-Acb NPY did not affect chow (181,210) and sucrose (210) intake. Interestingly, a recent study showed that intra-Acb NPY increased intake of sucrose pellets (62), which implies that intra-Acb NPY may increase sucrose intake in the absence of fat, or that the effect is specific to solid and not liquid sugar. NPY has been associated with carbohydrate intake in a number of studies (56, 57, 181 ), yet NPY is often administered in the third ventricle or directly into hypothalamic areas. In this study, NPY was directed to the Acb and specifically increased fat intake, suggesting that the effect of NPY on food component consumption may be dependent on the specific brain site. Basal caloric intake in rats on the fcHFHS diet comprises 50% from chow, 30% from sugar and 20% from fat. Because fat is not the main preferred component under baseline conditions with this diet, we infer that NPY-induced fat intake is not confounded by a pre-existing baseline fat preference.
Our findings indicate that NPY inhibits neuronal activity in the Acb. To our knowledge, this is the first study investigating the effects of NPY on Acb neuronal activity. The inhibitory effects in the Acb are in consistent with NPY's inhibitory effects in other brain areas, such as the amygdala and ARC (234,235), and coincide with the downregulation of ppENK mRNA expression upon intra-Acb NPY administration, another novel finding in this study. This may suggest that NPY's feeding effects in the Acb may occur via downregulation of D2-containing ENK neurons. The ability of NPY to reduce neuronal firing in the Acb is consistent with a general model from other pharmacological and electrophysiological studies in which reduced Acb neuronal firing stimulates food intake (232, 233) . Future studies are needed to determine the precise mechanism underlying NPY's inhibitory actions in the Acb.
Mu-opioid receptor agonists (such as DAMGO) elicit robust feeding responses, however administration of different doses of Met-enkephalin or a synthetic and proteaseresistant analogue of enkephalin ([D-Ala2] Met-enkephalin) in different Acb regions did not produce any significant effects on food intake (250). The majority of enkephalin neurons co-express GABA (251). Therefore, the NPY-mediated downregulation of ppENK neurons may also represent a reduction of GABA-ergic output. Reduced Acb GABA-ergic output has consistently been shown to elicit intense feeding in satiated rats and to increase intake of palatable foods (36, 231, 233, 252, 253) . This reduced Acb GABAergic output likely affects food intake via the lateral hypothalamus and medial ventral pallidum (254). The downstream outputs from the LH involve autonomic structures and structures that directly control brainstem pattern generators for the motor actions of eating (208). Therefore, we speculate that the downstream mechanisms of the inhibitory effects of NPY in the Acb (leading to the increase in fat intake) involve reduced GABAergic output to the LH via the medial ventral pallidum.
We demonstrated CTB tracing and NPY staining in brain areas consistent with others (238,255). However, colocalization was only found in the ARC, suggesting that NPY neurons projecting to the Acb predominantly originate from the ARC. Although it remains to be determined whether ARC-derived NPY is the principal mediator in palatable feeding regulation when rats are on the fcHFHS diet, the NPY-ergic ARC projections to the Acb supplement findings describing a-MSH projections from the ARC to the Acb (239), and suggest that afferent signals from ARC to Acb provide input about the general metabolic state of the body. Receptors of nearly all known metabolic hormones, such as leptin, insulin, glucocorticoid and ghrelin, are present on ARC NPY neurons. It remains to be explored whether the NPY neurons that project to the Acb are also controlled by these peripheral signals.
In conclusion, our data indicate a role for NPY in the Acb in the intake of palatable food, which is likely mediated by inhibition of enkephalin neurons, probably leading to decreased GABA-ergic output. Future studies are needed to establish a direct role of GABA-ergic enkephalin neurons in NPY's effect on fat intake. Our findings confirm and extend research suggesting a role for NPY in the feeding-related neural circuit controlled by the Acb (236,256,257). The feeding effects of the hypothalamic peptide NPY in the Acb further links the homeostatic and hedonic feeding circuits in the control and regulation of palatable feeding.
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SuPPLEMENTAL INFoRMATIoN Supplemental information for Material and Methods sections Surgery for cannulae in nucleus accumbens
Male Wistar rats (Charles River, Germany) weighing 270-300g were housed in a temperature (21-23ºC) and light-controlled room (lights on 0700-1900). One week after arrival, two cannulae aimed bilaterally at the Acb shell were implanted. Rats were anaesthetized with an ip injection of 80mg/kg ketamine (Eurovet Animal Health, Bladel, the Netherlands), 8mg/kg xylazine (Bayer Health Care, Mijdrecht, the Netherlands) and 0.1mg/ kg atropine (Pharmachemie B.V., Haarlem, the Netherlands) and fixed in a stereotaxic frame. Permanent 26-gauge stainless steel guide cannulae (Plastics One, Bilaney Consultants GmbH, Düsseldorf, Germany) were implanted at AP:+1.4 mm, ML:+/-2.8 mm, DV:-6.6 mm (coordinates from bregma and using an angle of 10° in the frontal plane). Guide cannulae were secured to the skull using four anchor screws and dental cement and occluded by a 28-gauge stainless steel dummy cannula (Plastics One, Bilaney Consultants GmbH, Düsseldorf, Germany). Immediately after surgery, rats received an analgesic subcutaneously (Carprofen, 0.5mg/100g body weight) and were housed individually.
Radioactive in situ hybridization
Sections were defrosted and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min, washed in PBS, pretreated with 0.25% acetic anhydride in 0.1 M triethanolamine, washed again in PBS and dehydrated in graded ethanol followed by 100% chloroform and 100% ethanol. The sections were hybridized overnight at 72°C with 10 6 cpm 33 P-labeled (33P-UTP, Perkin Elmer) antisense ppENK RNA probe in buffer containing 50% deionized formamide, 2× standard saline citrate (SSC), 10% dextrane sulphate, 1× Denhardt's solution, 5 mM EDTA and 10 mM phosphate buffer, after 5 min heating at 80°C. After hybridization, the sections were washed in 5×SSC (short, 72°C) and 0.2×SSC (2 h, 72°C) and dehydrated in graded ethanol in 0.3 M ammonium acetate. Sections were exposed to X-ray film (Kodak Bio-Max MR, Sigma-aldrich, Zwijndrecht, the Netherlands) for 4 days. The films were developed and expression levels were quantitatively analyzed using an 8800F Canon scanner. All images (600 dpi) were analyzed using ImageJ (Rasband, WS, NIH, Bethesda, MD, USA, http://rsbweb. nih.gov/ij /, 1997-2005) . In each section gray values were determined in the region of interest, measured bilaterally and subtracted from background, producing a single value for each brain area on each section.
Fluorescent immunohistochemistry
Coronal slices of 35 μm were cut in a cryostat and collected and stored until processing in cryoprotectant (30% glycerol, 30% ethylene glycol, 40% 0.1M PBS). Free floating slices were washed in PBS at least 5 times for a total of 60 min and were incubated in blocking buffer (2.5% normal donkey serum, 2.5% normal goat serum, 1% bovine serum albumin, 1% glycine, 1% lysine, 0.4% Triton X-100) for at least 30 min at room temperature (RT). Sections were incubated overnight in rabbit anti-NPY (1:1000, Niepke 091188, Netherlands Institute for Brain Research) primary antibody diluted in blocking buffer. The next day, slices were washed in PBS several times for a total of 60 min. Subsequently, sections were incubated with donkey anti-rabbit Alexa Fluor-488 (Invitrogen) secondary antibody diluted in blocking buffer for 1h at RT. After 5 washes in PBS for a total of 60 min at RT, sections were mounted on glass slides and embedded in mounting medium containing DAPI (Vectashield, Vector labs, Burlingame, CA, USA). Cholera toxin B (CTB)-alexa-555 conjugate emission was sufficient to visualize under the fluorescent microscope without additional CTB antibodies. Images were first taken by fluorescent microscopy and colocalization across all sections was determined by confocal microscope scanning.
Surgery for cannula and microwire electrode in nucleus accumbens for neural recordings in mice Anesthesia was initiated with ~4% isofluorane and intraperitoneal injections of ketamine (100mg/kg) and xylazine (10mg/kg). A surgical level of anesthesia was maintained over the course of surgery with supplements (30mg/kg) of ketamine every 45-60 min. The skull was leveled between bregma and lambda and a craniotomy was created over the ventral striatum. A single array of microwire electrodes was placed centered at AP:+1.2, ML:±0.7, DV:−4.5 (coordinates from bregma). A single infusion cannula was then placed at AP:+1.4, ML:±2.1, DV:−4.6 (coordinates from bregma and using an angle of 15° in the frontal plane). Craniotomies were sealed with cyanoacrylate ("Metabond") and methyl methacrylate (i.e., dental cement; AM Systems, Carlsborg, WA, USA).
Fluorescent in situ hybridization
For the fluorescent in situ hybridization analysis, fresh frozen mouse brains were cryosectioned at 14μm thickness and dried onto slides. The sections were then fixed in ice-cold 4% paraformaldehyde for 20 min, dehydrated in an ethanol series and allowed to air dry. The sections were rehydrated, acetylated for 10 min, dehydrated and air dried again. The hybridization mix (50% formamide, 5×SSC, 5×Denhardt's solution, 250μg/ml yeast RNA, 0.5mg/ml salmon testes DNA, and 300ng/ml RNA probe) was then added to the slides, which were incubated in humidified chambers at 60°C overnight. After washing and blocking with 5% normal rabbit IgG and 1% blocking reagent (Roche), the Y1R probe was first detected by using a 1:200 anti-digoxigenin antibody coupled to HRP (Dako, Carpinteria, CA, USA). The digoxigenin signal was amplified and detected using tyramide signal amplification (TSA)-direct coupled to cyanine-3 (PerkinElmer, Wellesley, MA, USA). Hydrogen peroxide treatment (3%, 15 min) was used to eliminate HRP activity. The fluorescein-labeled probe was detected with 1:500 rabbit anti-fluorescein coupled to HRP (Molecular Probes), followed by amplification with TSA-direct coupled to fluorescein (PerkinElmer). The sections were then dehydrated and mounted in DPX (Fluka, Neu-Ulm, Germany).
Generation of fluorescent in situ hybridization probes
Amplification products obtained by PCR were gel-purified and cloned into pCR2-TOPO vector (Invitrogen, Carlsbad, CA) and transformed into One Shot TOP10 competent cells (Invitrogen), using standard techniques. Positive clones were verified by diagnostic restriction enzyme digest and amplicon sequencing. To generate antisense digoxigenin (DIG)-labeled Y1R cRNA probe, plasmid was linearized by digestion with BAMHI and subjected to in vitro transcription with T7 RNA polymerase according to the manufacturer's protocol (Roche, Basel, Switzerland). For generation of sense DIG-labeled Y1R cRNA probe, plasmids were linearized by digestion with EcoRV and subjected to in vitro transcription with SP6 RNA polymerase. To generate antisense fluorescein-labeled ppENK and pDYN cRNA probes, plasmids were linearized by digestion with BAMHI for ppENK and EcoRV for pDYN and subjected to in vitro transcription with T7 RNA polymerase (for ppENK) and SP6 (for pDYN) according to the manufacturer's protocol (Molecular Probes, Eugene, OR, USA). Hybridization with sense probes was included as control experiment to confirm the specificity of the in situ hybridization protocol. These sense hybridization probes did not show any fluorescent hybridization signal. (Fig 1B; 2-way RM ANOVA: effect of NPY F(1, 10)=4.6; p=0.06); effect of Supplemental Figure S1 . Effect of intra-Acb NPY on 5h (A) and 24h (B) intake of chow, sugar and fat component. The intake of chow, sugar and fat are not increased after 5h and 24h after NPY administration in the Acb of rats.
Supplemental Figure S2 . Effect of pretreatment with NPY Y1 receptor antagonist (Y1a) on NPYinduced fat intake. Rats with unilateral or bilateral cannula placement in the Acb shell showed increased fat intake, consistent with Fig 1A. Pretreatment with Y1a did not significantly attenuate the NPY-induced fat intake (Fig 1B; 2-way RM ANOVA: effect of NPY F(1, 10)=4.6; p=0.06); effect of pretreatment F(1,10)=5.3; p=0.04), but no interaction effect of NPY* pretreatment F(1,10)=1.0; p=0.34); post hoc: * p<0.05. Interestingly, only when the Y1 antagonist was infused bilaterally in the medial shell, NPY's effects on fat intake were completely abolished, suggesting an important role of the medial shell in the Y1 mediated effects and that the Y1R in the Acb-shell is involved in the effect of NPY on fat intake
